Trial site
Piedmont Cancer Institute
- 11running trials
- 4closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Metastatic breast cancer3 trials
- Pancreatic cancer3 trials
- Bladder cancer2 trials
- Prostate cancer2 trials
- Triple-negative breast cancer2 trials
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Liver and biliary tract cancer1 trial
- Melanoma1 trial
- Phase
- Phase 39 trials
- Phase 1/22 trials
- Phase 22 trials
- Status
- Recruiting7 trials
- Active, not recruiting4 trials
- Completed2 trials
- Terminated2 trials
- Lead sponsor
- Gilead Sciences2 trials
- Janssen Research & Development, LLC2 trials
- Astellas Pharma Global Development, Inc.1 trial
- BioNTech SE1 trial
- Boehringer Ingelheim1 trial
- and 8 more
Running trials
Recruiting
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Recruiting
Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Active, not recruiting
A Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Pancreatic cancer2 recruiting
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Melanoma1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Terminated
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
Terminated
Site data: ClinicalTrials.govUpdated 18 Nov 2026